WA
WST icon

Winfield Associates’s West Pharmaceutical WST Stock Holding History

Winfield Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5
Closed -$1K – 667
2017
Q4 		$1K Buy
+5
New +$490 ﹤0.01% 799
2017
Q2 		– Sell
-30
Closed -$2K – 917
2017
Q1 		$2K Hold
30
– – ﹤0.01% 616
2016
Q4 		$3K Buy
+30
New +$2.36K ﹤0.01% 528

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Winfield Associates's WST Position: Q1 2018 in Review

Winfield Associates sold out of West Pharmaceutical (WST) in Q1 2018, closing a stake of 5 shares — an estimated $1K sold.

Winfield Associates first reported a position in WST in Q4 2016 and held it in 3 quarters. The position peaked at $3K in Q4 2016. 323 funds tracked by Wall St. Rank hold WST as of Q1 2018.

  • Winfield Associates reported no remaining West Pharmaceutical position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 5 West Pharmaceutical shares in Q1 2018, an estimated $1K.
  • Winfield Associates first reported a position in West Pharmaceutical in Q4 2016 and held it in 3 quarters.
  • Winfield Associates's West Pharmaceutical position peaked at $3K in Q4 2016.
  • 323 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.